US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Nexalin Technology, Inc.

< Previous 1 2 3 Next >
News headline image
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Closing of $5.2 Million Public Offering
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Pricing of $5.2 Million Public Offering
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Unveils Next-Generation HALO™ Clarity
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David Lasseter
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain Structures
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin’s tACS Devices in the Asia Pacific Region
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
News headline image
Nexalin Technology CEO Provides Letter to Shareholders
From Nexalin Technology, Inc.
Via GlobeNewswire
Tickers NXL NXLIW
< Previous 1 2 3 Next >